Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 11743651)

1.

Gene expression profiling in osteoclast precursors by insulin using microarray analysis.

Kim HS, Lee NK.

Mol Cells. 2014 Nov;37(11):827-32. doi: 10.14348/molcells.2014.0223. Epub 2014 Nov 5.

2.

Roles of Polo-like kinase 3 in suppressing tumor angiogenesis.

Xu D, Wang Q, Jiang Y, Zhang Y, Vega-Saenzdemiera E, Osman I, Dai W.

Exp Hematol Oncol. 2012 Apr 18;1(1):5. doi: 10.1186/2162-3619-1-5.

3.

Mitotic Kinases and p53 Signaling.

Ha GH, Breuer EK.

Biochem Res Int. 2012;2012:195903. doi: 10.1155/2012/195903. Epub 2012 Jul 19.

4.

Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation.

Tell R, Wang QT, Blunier A, Benya RV.

Clin Epigenetics. 2011 Aug;2(2):331-8. doi: 10.1007/s13148-011-0027-5. Epub 2011 Mar 29.

5.

Types and amount of dietary fat and colon cancer risk: Prevention by omega-3 fatty acid-rich diets.

Reddy BS.

Environ Health Prev Med. 2002 Jul;7(3):95-102. doi: 10.1265/ehpm.2002.95.

6.

Calcium- and integrin-binding protein 1 regulates microtubule organization and centrosome segregation through polo like kinase 3 during cell cycle progression.

Naik MU, Naik UP.

Int J Biochem Cell Biol. 2011 Jan;43(1):120-9. doi: 10.1016/j.biocel.2010.10.003. Epub 2010 Oct 15.

7.

Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells.

Naik MU, Pham NT, Beebe K, Dai W, Naik UP.

Int J Cancer. 2011 Feb 1;128(3):587-96. doi: 10.1002/ijc.25388.

8.

The balance of Polo-like kinase 1 in tumorigenesis.

Lu LY, Yu X.

Cell Div. 2009 Jan 22;4:4. doi: 10.1186/1747-1028-4-4.

9.

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.

Weichert W, Denkert C, Schmidt M, Gekeler V, Wolf G, Köbel M, Dietel M, Hauptmann S.

Br J Cancer. 2004 Feb 23;90(4):815-21.

10.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk